Forty five percent of the Israeli population were infected with the influenza B Victoria virus during the winter season 2015-16.

We report of high influenza B Victoria virus prevalence in the 2015-16 winter season in Israel, affecting approximately half of the Israeli population. We further show that the Victoria B virus infected individuals of all ages and that it was present in the country throughout the entire winter season. The vaccine however included the inappropriate Yamagata virus. We propose that a quadrivalent vaccine, that includes both Yamagata and Victoria lineages, should be considered for future influenza vaccination. PMID: 29464098 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/29464098?dopt=Abstract

Source: Oncotarget - February 23, 2018 Category: Cancer & Oncology Tags: Oncotarget Source Type: research